LOGOLOGOLOGOLOGO
  • About us
    • What we do
    • Who we are
      • Governance
      • Staff
      • Vacancies
  • Members
    • EuropaBio Members
    • About Membership
  • How we work
    • Healthcare Biotechnology Council
      • Patient BioForum
      • Study – Impact of the EU’s General Pharmaceutical Legislation
    • Industrial Biotechnology Council
      • EFIB
      • Microorganisms
    • National Associations Council
    • SME Platform
    • Biomanufacturing Platform
      • Biotechnology in our Lives
  • Activities
    • 25 Years of Innovation
    • The EU Biotech Act
    • European Biotech Week
    • EU Projects
      • PRIMED Project
      • APROVALS Project
  • News & Events
    • News
    • Events
  • Library
Become a member
✕

Joint statement on the EU Climate Law

26/05/2020
WHITE PAPER

Joint statement on the EU Climate Law

We the undersigned European Bioeconomy Alliance (EUBA), the Alliance for Beverage Cartons and the Environment and CITPA, representing various sectors active in packaging and the bioeconomy, support an ambitious Climate Law that recognizes the role of sustainable low carbon and circular materials, such as renewable materials, in achieving climate neutrality.

The EU Green Deal represents both an opportunity and a challenge for the bioeconomy sectors. We support the EU on its way to achieve climate neutrality by 2050 to protect the future of our planet by providing the inputs for a low carbon bioeconomy, while creating a sustainable competitive advantage for the European industry. Achieving climate neutrality requires the contribution of all sectors of the European economy, and clear incentives for developing climate-friendly and sustainable practices, products and technologies. While energy efficiency and renewable energy are fundamental to reach this objective, climate neutrality will only be possible by also cutting the emissions associated with the production, use and disposal of materials. Materials and manufactured products account for nearly one fifth of the total EU CO2 emissions (data from 2018).

It is, therefore, crucial that the Climate Law addresses the potential for climate change mitigation offered by materials and links climate policy with the circular economy.

Bioeconomy is one of the most successful examples of a European strategic value-chain. The bioeconomy sectors are instrumental players in the transition to a circular and climate neutral economy and are keen to pursue their continuous research & innovation efforts to make the EU Climate Law a success. The bioeconomy is already worth more than €2 trillion annually and employs over 18 million Europeans. By storing and utilizing carbon dioxide and replacing carbon intensive fossil-based resources, sustainably sourced renewable materials offer a key opportunity to help achieve Europe’s climate ambitions. By enabling the substitution of finite fossil-based materials and through their re-circulation in the economy thanks to recycling (mechanic, organic and chemical), renewable materials are also key for the European circular economy and security of supply of raw materials. The European Commission’s strategic long-term vision for 2050, “A Clean Planet for all", which is the Impact Assessment for the Climate Law, identifies the bioeconomy and the circular economy as key strategic areas to achieve a climate neutral economy. In the words of the long-term vision, “sustainable biomass has an important role to play in a net-zero greenhouse gas emissions economy”.

To fully unleash the contribution of a circular bioeconomy to climate neutrality, we suggest that the Climate Law:

Recognises the essential role of renewable and low carbon materials, in achieving climate neutrality. Mandates the Commission to assess (i) how existing EU legislation on materials and products can be revised to promote the use of renewable and low carbon materials with climate benefits that act as carbon sinks and/ or partially substitute fossil-based materials, and (ii) how existing regulatory and societal impediments to (technological) innovation can be addressed, to set the correct incentives and pave the way for the most effective solutions with which the formidable global challenges can be approached. Calls on Member States to assess the impacts of their planned policies on materials and products to meet the climate neutrality objective set by the Climate Law, as part of the regular update of their National Energy and Climate Plans (NECPs).

Joint Statement on EU Climate Law


Download
2020_05_I_WP_EUBA-Joint-Statement-on-the-EU-Climate-LawDownload
Share
Alexandra Simionca
Alexandra Simionca

Related posts

10/06/2025

EuropaBio Position on the EU Biotech Act: Prosperity, resilience and leadership for the European Union


Read more
10/06/2025

The EU economic and scientific future starts with the EU Biotech Act


Read more
04/06/2025

EuropaBio response to EC Call for evidence for an evaluation of “Apply AI Strategy – strengthening the AI continent”


Read more

Important links

  • EuropaBio Position on the EU Biotech Act: Prosperity, resilience and leadership for the European Union
  • The EU economic and scientific future starts with the EU Biotech Act

Categories in our Newsroom

EBIO-white

EuropaBio represents corporate and associate members across sectors, plus national and regional biotechnology associations which, in turn, represent over 5000 biotech companies, 4600 out of them are SMEs.

Contact us

Extra links

Members
Staff
Privacy policy
Legal & cookies
Events
Newsroom

Become a member

Media pack

© 2025 Europabio. All Rights Reserved. Designed by EYAS
Become a member

Algal Omega 3

Algal Omega-3 is an innovative feed product for aquaculture. It reduces the impact on climate change by 30-40% compared to fish oil and saves 60 tons of wild fish for every ton of Algal Omega-3 used.

Cheese

Cheese is a vegetarian product thanks to biotechnology. Biotechnology is also essential to produce lactose- or cholesterol-free cheese, as well as alternative proteins.

Clothes

Clothes made from alternative fibres produced by microorganisms can be 8x stronger than steel, 100% recyclable, biodegradable and replace fossil-fuel based or resource-intensive textiles.

Vitamin B2

The biomanufacturing of Vitamin B2 led to the reduction of 75% of fossil raw materials and 50% operating costs, compared to the chemical process. Vitamin B2 is used in the food, feed or healthcare sectors.

Detergents

Enzymes and biosurfactancts are alternative ingredients that improve the performance of detergents, while leading to water and energy savings and reductions in CO2 emissions and water toxicity.

Insulin

Insulin is one of the most widely known biopharmaceutical. Biotechnology revolutionised its manufacturing process and led to the development of new types of insulin through r-DNA technology.